title: Suppression of experimental aneurysmal degeneration with chemically modified tetracycline derivatives.
authors.affiliation: Department of Surgery, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
authors.forename: D
authors.initials: D
authors.lastname: Petrinec
authors.forename: D R
authors.initials: DR
authors.lastname: Holmes
authors.forename: S
authors.initials: S
authors.lastname: Liao
authors.forename: L M
authors.initials: LM
authors.lastname: Golub
authors.forename: R W
authors.initials: RW
authors.lastname: Thompson
mesh_terms: D000818:Animals; D017544:Aortic Aneurysm, Abdominal / Q000139:chemically induced / Q000188:drug therapy* / Q000201:enzymology; D002317:Cardiovascular Agents / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D004318:Doxycycline / Q000494:pharmacology / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008666:Metalloendopeptidases / Q000037:antagonists & inhibitors*; D010196:Pancreatic Elastase / Q000633:toxicity; D051381:Rats; D017208:Rats, Wistar; D013754:Tetracyclines / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D002317:Cardiovascular Agents; D004791:Enzyme Inhibitors; D013754:Tetracyclines; D010196:Pancreatic Elastase; D008666:Metalloendopeptidases; D004318:Doxycycline